As a chemokine receptor, CCR7 has been proven to be involved in lymphatic metastasis in various cancers, including ESCC [24, 25], and the role of the CCL21-CCR7 axis in inducing the directional migration and invasion of tumor cells has also been proven [26–29]. The gene discussed is CCR7; the disease is neoplasm.